{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:49:14Z","timestamp":1793386154773,"version":"4.5.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Critical components of successful evaluation of clinical outcome assessments (COAs) in multisite clinical trials and clinical practice are standardized training, administration, and documented reliability of scoring. Experiences of evaluators, alongside patient differences from regional standards of care, may contribute to heterogeneity in clinical center\u2019s expertise. Achieving low variability and high reliability of COA is fundamental to clinical research and to give confidence in our ability to draw rational, interpretable conclusions from the data collected. The objective of this manuscript is to provide a framework to guide the learning process for COAs for use in clinics and clinical trials to maximize reliability and validity of COAs in neuromuscular disease (NMD). This is a consensus-based guideline with contributions from fourteen leading experts in clinical outcomes and the field of clinical outcome training in NMD. This framework should guide reliable and valid assessments in NMD specialty clinics and clinical trials. This consensus aims to expedite study start up with a progressive training pathway ranging from research na\u00efve to highly experienced clinical evaluators. This document includes recommendations for education guidelines and roles and responsibilities of key stakeholders in COA assessment and implementation to ensure quality and consistency of outcome administration across different settings.<\/jats:p>","DOI":"10.3389\/fgene.2021.735936","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T12:19:41Z","timestamp":1636546781000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Consensus Guidelines for Improving Quality of Assessment and Training for Neuromuscular Diseases"],"prefix":"10.3389","volume":"12","author":[{"given":"Tina","family":"Duong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin J.","family":"Krosschell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith K.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay N.","family":"Alfano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Eichinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda P.","family":"Lowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mayhew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julaine","family":"Florence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia R.","family":"Senesac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Eagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/mus.880060204","article-title":"Clinical investigation in Duchenne dystrophy: 2. Determination of the \u201cpower\u201d of therapeutic trials based on the natural history.","volume":"6","author":"Brooke","year":"1983","journal-title":"Muscle Nerve"},{"key":"B2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/mus.880040304","article-title":"Clinical trial in Duchenne dystrophy. I. The design of the protocol.","volume":"4","author":"Brooke","year":"1981","journal-title":"Muscle Nerve"},{"key":"B3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1745-3984.2000.tb01081.x","article-title":"The stability of rater severity in large-scale assessment programs.","volume":"37","author":"Congdon","year":"2000","journal-title":"J. Educ. Meas."},{"key":"B4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1469-8749.2005.tb01038.x","article-title":"Effect of rater training on reliability of Melbourne Assessment of Unilateral Upper Limb Function scores.","volume":"47","author":"Cusick","year":"2005","journal-title":"Dev. Med. Child Neurol."},{"key":"B5","first-page":"19","article-title":"The problem of measurement error in multisite clinical trials.","volume":"34","author":"Demitrack","year":"1998","journal-title":"Psychopharmacol. Bull."},{"key":"B6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1682\/JRRD.2004.08.0098","article-title":"Neurological and functional capacity outcome measures: essential to spinal cord injury clinical trials.","volume":"42","author":"Ditunno","year":"2005","journal-title":"J. Rehabil. Res. Dev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/mus.1070","article-title":"Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children.","volume":"24","author":"Escolar","year":"2001","journal-title":"Muscle Nerve"},{"key":"B8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/ptj\/64.1.41","article-title":"Clinical trials in Duchenne dystrophy. Standardization and reliability of evaluation procedures.","volume":"64","author":"Florence","year":"1984","journal-title":"Phys. Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1001\/archpsyc.1981.01780360075007","article-title":"Mastering the Art of Research Interviewing: a Model Training Procedure for Diagnostic Evaluation.","volume":"38","author":"Gibbon","year":"1981","journal-title":"Arch. Gen. Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3233\/JND-180301","article-title":"Evaluator Training and Reliability for SMA Global Nusinersen Trials1.","volume":"5","author":"Glanzman","year":"2018","journal-title":"J. Neuromuscul. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1381","DOI":"10.1212\/WNL.0000000000010170","article-title":"Suitability of external controls for drug evaluation in Duchenne muscular dystrophy.","volume":"95","author":"Goemans","year":"2020","journal-title":"Neurology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/YIC.0b013e3280803dad","article-title":"A novel approach to rater training and certification in multinational trials.","volume":"22","author":"Jeglic","year":"2007","journal-title":"Int. Clin. Psychopharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jpsychires.2005.07.012","article-title":"Enriched rater training using Internet based technologies: a comparison to traditional rater training in a multi-site depression trial.","volume":"40","author":"Kobak","year":"2006","journal-title":"J. Psychiatr. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/01.jcp.0000116651.91923.54","article-title":"Rater training in multicenter clinical trials: issues and recommendations.","volume":"24","author":"Kobak","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/01.jcp.0000177666.35016.a0","article-title":"A new approach to rater training and certification in a multicenter clinical trial.","volume":"25","author":"Kobak","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3233\/JND-180327","article-title":"Motor Function Test Reliability During the NeuroNEXT Spinal Muscular Atrophy Infant Biomarker Study.","volume":"5","author":"Krosschell","year":"2018","journal-title":"J. Neuromuscul. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/mus.22040","article-title":"Reliability of the Modified Hammersmith Functional Motor Scale in young children with spinal muscular atrophy.","volume":"44","author":"Krosschell","year":"2011","journal-title":"Muscle Nerve"},{"key":"B18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/mus.20654","article-title":"Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy.","volume":"35","author":"Mayhew","year":"2007","journal-title":"Muscle Nerve"},{"key":"B19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.nmd.2016.05.016","article-title":"Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy.","volume":"26","author":"Mercuri","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1176\/appi.ajp.159.9.1598","article-title":"Interrater reliability in clinical trials of depressive disorders.","volume":"159","author":"Mulsant","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/00001416-201201000-00011","article-title":"Successful Model for Improving Student Retention in Physical Therapist Education Programs: a Case Report.","volume":"26","author":"Noonan","year":"2012","journal-title":"J. Phys. Ther. Educ."},{"key":"B22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/ptj\/74.3.253","article-title":"Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group.","volume":"74","author":"Personius","year":"1994","journal-title":"Phys. Ther."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.15694\/mep.2019.000202.1","article-title":"Guidelines for Evaluating Clinical Research Training using Competency Assessments.","volume":"8","author":"Samuels","year":"2019","journal-title":"MedEdPublish"},{"key":"B24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/sj.sc.3102008","article-title":"Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures.","volume":"45","author":"Steeves","year":"2007","journal-title":"Spinal Cord"},{"key":"B25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/01.jcp.0000219049.33008.b7","article-title":"Evaluating rater competency for CNS clinical trials.","volume":"26","author":"Targum","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3109\/16066359.2013.868446","article-title":"Research staff training in a multisite randomized clinical trial: methods and recommendations from the Stimulant Reduction Intervention using Dosed Exercise (STRIDE) trial.","volume":"22","author":"Walker","year":"2014","journal-title":"Addict. Res. Theory"},{"key":"B27","first-page":"256","article-title":"Detecting differential rater functioning over time (DRIFT) using a Rasch multi-faceted rating scale model.","volume":"2","author":"Wolfe","year":"2001","journal-title":"J. Appl. Meas."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.735936\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T12:19:47Z","timestamp":1636546787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.735936\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,10]]},"references-count":27,"alternative-id":["10.3389\/fgene.2021.735936"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2021.735936","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,10]]},"article-number":"735936"}}